Harnessing the power
of the immune system

 

Merck scientists talk about being on the verge of a new era in cancer therapy

Merck’s immuno-oncology researchers are focused on finding ways to help the immune system recognize cancer cells as well as strengthen the body’s response to destroy them.

Watch the Video

Here, Eric Rubin, vice president, Clinical Research, Oncology Early Development; Reshma Rangwala, senior principal scientist, Clinical Research; and Scot Ebbinghaus, executive director, Clinical Research, Oncology, talk about their work in this space and how they are committed to finding ways to transform how we treat cancer.

When we get new data, it’s truly an exciting event not only for me personally but for the entire team of physicians and scientists who work with me every single day.

— Reshma Rangwala
senior principal scientist, Clinical Research

Learn more about Immuno-Onocology

View Infographic